Filing Details

Accession Number:
0000939767-17-000148
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-14 19:17:16
Reporting Period:
2017-09-12
Accepted Time:
2017-09-14 19:17:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
939767 Exelixis Inc. EXEL Services-Commercial Physical & Biological Research (8731) 043257395
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1648367 J. Christopher Senner C/O Exelixis, Inc.
210 East Grand Ave.
South San Francisco CA 94080
Evp And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-09-12 100,000 $3.66 202,759 No 4 M Direct
Common Stock Disposition 2017-09-12 100,000 $26.79 102,759 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (right to buy) Disposition 2017-09-12 100,000 $0.00 100,000 $3.66
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
250,000 2016-07-15 2022-07-14 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,039 Indirect By 401(k)
Footnotes
  1. Includes 20,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 2,361 shares of common stock acquired pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan on April 28, 2017.
  2. Represents 2,039 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of September 12, 2017.
  3. The option, representing the right to purchase a total of 350,000 shares of Exelixis, Inc. common stock, was exercisable as to 182,291 shares on the Transaction Date. Th remainder of the option will vest as to 1/48th of the original number of shares subject to the option on each monthly anniversary of July 15, 2015 grant date.